tiprankstipranks
Advertisement
Advertisement

Hyperfine Secures $40 Million Term Loan Financing Agreement

Story Highlights
  • On March 18, 2026, Hyperfine secured up to $40 million in senior secured term loans, drawing $15 million immediately for working capital.
  • Hyperfine complemented the loan with equity-linked warrants to Horizon, balancing added leverage with potential dilution and tighter covenant constraints.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Hyperfine Secures $40 Million Term Loan Financing Agreement

Claim 30% Off TipRanks

Hyperfine ( (HYPR) ) has shared an update.

On March 18, 2026, Hyperfine, Inc. entered into a Loan and Security Agreement with Horizon Technology Finance Corporation for a senior secured term loan facility of up to $40 million, of which $15 million was drawn at closing for working capital and general corporate purposes. The remaining $25 million may be accessed through 2027 subject to conditions, with the loan carrying a minimum interest rate of 10.75%, interest-only payments for up to 48 months, a potential extension to 2031, and customary covenants and default provisions secured against substantially all company assets.

In connection with the financing, Hyperfine issued Horizon warrants to purchase up to 1,083,335 shares of Class A common stock at $1.20 per share, with a portion exercisable immediately and the remainder tied to future loan fundings. The structure of the facility, including prepayment premiums, a final fee upon repayment, and warrant-based equity participation, provides Hyperfine with non-dilutive debt capacity in the near term while adding leverage and covenant constraints that will shape its capital structure and operational flexibility going forward.

The most recent analyst rating on (HYPR) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Hyperfine stock, see the HYPR Stock Forecast page.

Spark’s Take on HYPR Stock

According to Spark, TipRanks’ AI Analyst, HYPR is a Neutral.

The score is held back primarily by weak financial performance (volatile/declining TTM revenue, large operating losses, and substantial cash burn). Offsetting this are improving operational indicators from recent updates and the earnings call (record gross margin, stronger revenue trajectory, better cash-burn control, and extended runway), plus supportive technical momentum; valuation remains constrained by ongoing losses and no dividend yield.

To see Spark’s full report on HYPR stock, click here.

More about Hyperfine

Hyperfine, Inc. is a medical technology company focused on advanced imaging solutions, including portable MRI systems aimed at expanding access to neuroimaging at the point of care. The company targets hospitals and healthcare providers seeking cost-effective, bedside imaging capabilities that can improve diagnostic workflows and patient management in critical and resource-constrained settings.

Average Trading Volume: 500,804

Technical Sentiment Signal: Buy

Current Market Cap: $126.3M

See more data about HYPR stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1